New SLE (systemic lupus erythematosus) diagnostic test available for licensing
This article was originally published in Clinica
Executive Summary
Commercial partners are being sought to exploit a new test for diagnosing systemic lupus erythematosus (SLE), developed by researchers at the Fred Hutchinson Cancer Research Center in Seattle, Washington. The Hutchinson Center has filed for patent protection for the test, which is claimed to be able to identify the 20% of SLE patients who are not detected by current methods.